Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators. Pivot X, et al. Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178155 Clinical Trial.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Tubiana-Mathieu N, Cany L, Catala S, Khayat D, Pauporté I, Kramar A; PHARE trial investigators. Pivot X, et al. Lancet Oncol. 2013 Jul;14(8):741-8. doi: 10.1016/S1470-2045(13)70225-0. Epub 2013 Jun 11. Lancet Oncol. 2013. PMID: 23764181 Clinical Trial.
[Institution Nationale des Invalides today].
Lefebvre P, Lagrave G, Nadeau G, Thévenot H, Dumurgier C. Lefebvre P, et al. Among authors: thevenot h. Bull Acad Natl Med. 1988 Nov;172(8):1199-204. Bull Acad Natl Med. 1988. PMID: 3073845 French. No abstract available.
Cancer incidence in the islands of the Pacific.
Henderson BE, Kolonel LN, Dworsky R, Kerford D, Mori E, Singh K, Thevenot H. Henderson BE, et al. Among authors: thevenot h. Natl Cancer Inst Monogr. 1985 Dec;69:73-81. Natl Cancer Inst Monogr. 1985. PMID: 3834349
[Occurrence of thyroid cancer in New Caledonia].
Thevenot H, Vindrios J, Lebourgeois M, Floch JJ. Thevenot H, et al. Presse Med. 1984 Apr 21;13(17):1096-7. Presse Med. 1984. PMID: 6232538 French. No abstract available.
[4 years of oncological statistics in New Caledonia].
Guelain J, Bahuaud J, Germain R, Peghini M, Schill H, Thevenot H, Charpin M. Guelain J, et al. Among authors: thevenot h. Med Trop (Mars). 1983 May-Jun;43(3):289-98. Med Trop (Mars). 1983. PMID: 6888233 French. No abstract available.
[Heart tumors. Apropos of 16 cases].
Dallocchio M, Fontan F, Baudet E, Choussat A, Daubeze J, Thevenot H, Giraudet C, Clementy J, Bricaud H, Broustet P. Dallocchio M, et al. Among authors: thevenot h. Ann Cardiol Angeiol (Paris). 1973 Mar-Apr;22(2):127-37. Ann Cardiol Angeiol (Paris). 1973. PMID: 4704434 French. No abstract available.